Legis Daily

Affordable and Safe Prescription Drug Importation Act

USA116th CongressHR-447| House 
| Updated: 1/25/2019
Elijah E. Cummings

Elijah E. Cummings

Democratic Representative

Maryland

Cosponsors (26)
John Garamendi (Democratic)Barbara Lee (Democratic)Mark Pocan (Democratic)James R. Langevin (Democratic)Sheila Jackson Lee (Democratic)Debra A. Haaland (Democratic)Ilhan Omar (Democratic)Steve Cohen (Democratic)Rosa L. DeLauro (Democratic)Ro Khanna (Democratic)Mark DeSaulnier (Democratic)Raja Krishnamoorthi (Democratic)Pramila Jayapal (Democratic)Eleanor Holmes Norton (Democratic)Brad Sherman (Democratic)Tulsi Gabbard (Democratic)Jamie Raskin (Democratic)Joe Neguse (Democratic)Janice D. Schakowsky (Democratic)Alexandria Ocasio-Cortez (Democratic)Peter Welch (Democratic)Earl Blumenauer (Democratic)Rashida Tlaib (Democratic)Lloyd Doggett (Democratic)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Affordable and Safe Prescription Drug Importation Act This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2019

Latest Companion Bill Action

S 116-97
Introduced in Senate
Jan 10, 2019
Introduced in House
Jan 10, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.
  • January 10, 2019

    Latest Companion Bill Action

    S 116-97
    Introduced in Senate


  • January 10, 2019
    Introduced in House


  • January 10, 2019
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 116-1801: Affordable Medications Act
  • HR 116-1478: Affordable Insulin Act of 2019
  • S 116-97: Affordable and Safe Prescription Drug Importation Act
Administrative law and regulatory proceduresCanadaCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsPrescription drugsTrade restrictionsUser charges and fees

Affordable and Safe Prescription Drug Importation Act

USA116th CongressHR-447| House 
| Updated: 1/25/2019
Affordable and Safe Prescription Drug Importation Act This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2019

Latest Companion Bill Action

S 116-97
Introduced in Senate
Jan 10, 2019
Introduced in House
Jan 10, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.
  • January 10, 2019

    Latest Companion Bill Action

    S 116-97
    Introduced in Senate


  • January 10, 2019
    Introduced in House


  • January 10, 2019
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2019
    Referred to the Subcommittee on Health.
Elijah E. Cummings

Elijah E. Cummings

Democratic Representative

Maryland

Cosponsors (26)
John Garamendi (Democratic)Barbara Lee (Democratic)Mark Pocan (Democratic)James R. Langevin (Democratic)Sheila Jackson Lee (Democratic)Debra A. Haaland (Democratic)Ilhan Omar (Democratic)Steve Cohen (Democratic)Rosa L. DeLauro (Democratic)Ro Khanna (Democratic)Mark DeSaulnier (Democratic)Raja Krishnamoorthi (Democratic)Pramila Jayapal (Democratic)Eleanor Holmes Norton (Democratic)Brad Sherman (Democratic)Tulsi Gabbard (Democratic)Jamie Raskin (Democratic)Joe Neguse (Democratic)Janice D. Schakowsky (Democratic)Alexandria Ocasio-Cortez (Democratic)Peter Welch (Democratic)Earl Blumenauer (Democratic)Rashida Tlaib (Democratic)Lloyd Doggett (Democratic)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-1801: Affordable Medications Act
  • HR 116-1478: Affordable Insulin Act of 2019
  • S 116-97: Affordable and Safe Prescription Drug Importation Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCanadaCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsPrescription drugsTrade restrictionsUser charges and fees